Fullerton Health Group
Corporate brand
UnclaimedFullerton Health Group is a Singapore-founded enterprise healthcare provider serving corporate employers, insurers, patients, and healthcare networks across Asia-Pacific.
Last updated August 31, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Fullerton Health Group is an integrated enterprise healthcare services company founded in Singapore in 2010. Rather than operating primarily as a conventional consumer hospital or retail clinic chain, the group focuses on designing and administering healthcare programs for corporations, insurers, employees, and other institutional clients. Its services combine clinical delivery, managed healthcare, medical benefits administration, healthcare assistance, diagnostic imaging, and access to networks of hospitals, clinics, and other medical providers. The business was established through an initial investment in corporate healthcare providers including Gethin-Jones and Drs Trythall Hoy Davies. It subsequently expanded through a combination of organic growth, regional network development, and acquisitions. Beginning in 2011, Fullerton Health extended its presence beyond Singapore into Malaysia, Indonesia, and Hong Kong. By 2022, the company reported operations in nine Asia-Pacific countries, although the available reference material does not identify every market. A major phase of expansion occurred in 2015, when the group completed three significant transactions. Its subsidiary Global Assistance & Healthcare acquired PT JLT GESA, commonly known as Medilum, an Indonesian provider of managed healthcare and third-party administration services. Fullerton also acquired an 80 percent interest in Hong Kong medical provider HMMP Limited for S$33 million. In Singapore, its purchase of Radlink-Asia for S$111.2 million broadened the group into advanced diagnostic imaging and supported greater digitisation of healthcare processes. The acquisitions were accompanied by rapid growth. Revenue was reported at S$163.8 million in 2014 and S$240.6 million in 2015. By 2016, Fullerton Health said it had nearly 400 medical professionals, more than 1,000 support employees, approximately 8,000 associate hospitals and clinics, and 198 clinics and facilities across Singapore, Hong Kong, Indonesia, and Malaysia. It reported nearly 2,000 employees, around four million patient visits per year, services reaching approximately 10 million people, and relationships with about 25,000 companies. Corporate customers cited in reference material include Marina Bay Sands, Standard Chartered Bank, Singapore Airlines, and employees of other multinational and small-to-medium-sized enterprises. The group also experienced corporate and financial pressure. In 2021, efforts to obtain new financing were nearly disrupted by disagreements within the company. Founders subsequently initiated winding-up proceedings, which were later withdrawn. In 2025, Mitsubishi Corporation invested in Fullerton Health as part of its broader regional healthcare expansion strategy. The available material does not state the investment amount, ownership percentage, or detailed transaction structure. Fullerton Health's business model places it between healthcare delivery and healthcare administration. Its corporate and insurer-facing approach allows employers to outsource parts of medical benefits management, provider access, claims-related administration, employee healthcare delivery, and assistance services. Its regional network and acquisition strategy have been central to its effort to provide cross-border healthcare infrastructure for institutional customers. The company remains an active Asia-Pacific healthcare group, but detailed current ownership, leadership, financial performance, and market-by-market operations require additional verification.
History
Fullerton Health Group was founded in Singapore in 2010 as an enterprise healthcare services provider. Its early development was based on investment in established corporate healthcare providers, including Gethin-Jones and Drs Trythall Hoy Davies. This gave the group an initial clinical and institutional platform from which to develop services for corporate employers and insurers. From 2011 onward, Fullerton expanded regionally, entering Malaysia, Indonesia, and Hong Kong. Its growth model combined the construction of healthcare networks with mergers and acquisitions. The company developed a role as an intermediary and service operator connecting employers and insurers with clinics, hospitals, doctors, diagnostic providers, and healthcare administrators. By 2016, it reported close to 400 medical professionals, over 1,000 support employees, and a network of more than 8,000 associate hospitals and clinics. The group recorded substantial revenue growth during the middle of the 2010s. Revenue was reported at S$163.8 million in 2014, followed by 46.9 percent growth to S$240.6 million in 2015. That expansion coincided with three important acquisitions. In May 2015, Global Assistance & Healthcare, a Fullerton subsidiary, acquired PT JLT GESA, or Medilum, in Indonesia. Medilum provided managed healthcare and third-party administration services, strengthening Fullerton's capabilities in administering medical programs and insurer or employer relationships. In August 2015, Fullerton purchased an 80 percent stake in Hong Kong medical provider HMMP Limited for S$33 million. The deal expanded its presence in Hong Kong and added local medical delivery capacity. The company also acquired Radlink-Asia in Singapore for S$111.2 million. Radlink-Asia brought advanced diagnostic imaging into the group and was associated with efforts to reduce costs and improve operating processes through digitisation. By 30 June 2016, Fullerton Health reported 198 clinics and facilities across Singapore, Hong Kong, Indonesia, and Malaysia, with close to 2,000 employees. It reported more than S$300 million in annual revenue, approximately four million patient visits each year, services reaching about 10 million people, and relationships with roughly 25,000 companies across Asia-Pacific. Its corporate customer base included large employers such as Marina Bay Sands, Standard Chartered Bank, and Singapore Airlines, as well as multinational companies and small and medium-sized businesses. The company's subsequent history included financial restructuring pressure and governance disputes. In 2021, a financing effort was nearly disrupted by disagreements among internal stakeholders. Founders initiated winding-up proceedings, but those proceedings were later withdrawn. The available material does not provide sufficient detail to establish the complete financing structure, the parties' precise claims, or the final terms of the withdrawn proceedings. In 2025, Mitsubishi Corporation invested in Fullerton Health in connection with the Japanese conglomerate's regional healthcare expansion. The investment represented a further connection between Fullerton's Asia-Pacific healthcare platform and a major strategic investor, although the available source does not disclose the investment amount or ownership terms. The group has also faced legal and reputational issues involving former executives. In 2025, co-founder David Sin was fined S$160,000 for approving falsified claims exceeding S$213,000. The conduct related to claims submitted in 2019. In 2026, former deputy group chief executive Daniel Chan Pai Sheng and former group chief executive Michael Tan Kim Song were fined over false or inflated entertainment-expense claims. These proceedings concern former executives and do not, on the available information, establish that the company's current operations or current management engaged in the conduct. Fullerton Health's historical development therefore combines regional healthcare expansion, acquisition-led diversification, and a business model built around corporate and insurer healthcare administration. Its present scale, precise ownership, current executive team, and full list of operating countries require further source verification.
- 2025
Mitsubishi Corporation investment
[1]Mitsubishi Corporation invested in Fullerton Health as part of its regional healthcare expansion.
- 2022
Operations reported in nine Asia-Pacific countries
[1]Reference material states that Fullerton had operations in nine countries in the Asia-Pacific region.
- 2021
Financing difficulties and withdrawn winding-up proceedings
[1]A financing process was nearly disrupted by internal disagreements, followed by winding-up proceedings initiated by founders and later withdrawn.
- 2016
Reported regional operating scale
[1]The group reported 198 clinics and facilities, nearly 2,000 employees, more than S$300 million in annual revenue, and a network of approximately 8,000 associate hospitals and clinics.
- 2015
Three major acquisitions completed
[1]Fullerton expanded in Indonesia, Hong Kong, and Singapore through the acquisitions of Medilum, an 80 percent stake in HMMP Limited, and Radlink-Asia.
- 2014
Revenue reached S$163.8 million
[1]The company reported revenue of S$163.8 million after more than doubling its revenue growth by that point.
- 2011
Regional expansion began
[1]Fullerton began expanding beyond Singapore into Malaysia, Indonesia, and Hong Kong.
- 2010
Fullerton Health Group founded in Singapore
[1]The enterprise healthcare provider was established in Singapore, initially building on investments in corporate healthcare providers.
Products and positioning
A regional, enterprise-focused healthcare platform that combines clinical services, provider networks, healthcare administration, assistance, and diagnostics for employers and insurers.
Enterprise healthcare
Corporate healthcare programs
Customized healthcare programs designed for employers and their workforces. These programs may combine clinical access, outpatient services, provider networks, employee medical benefits, and administrative support, allowing corporate customers to coordinate healthcare delivery across multiple locations.
Healthcare administration
Managed healthcare and third-party administration
Managed-care and third-party administration services for employers, insurers, and other institutional customers. The business includes organizing provider access and administering healthcare arrangements, with the Medilum acquisition strengthening Fullerton's capabilities in Indonesia.
Medical assistance
Healthcare assistance services
Healthcare assistance capabilities delivered through the group's assistance businesses and regional provider relationships. These services support institutional customers and patients by coordinating access to medical providers and related healthcare resources.
Medical diagnostics · 2015
Diagnostic imaging
Advanced diagnostic imaging services brought into the group through the acquisition of Radlink-Asia in Singapore. The transaction expanded Fullerton beyond corporate medical administration and supported the digitisation of processes intended to improve efficiency and control costs.
Provider networks
Clinic and hospital network access
Access to a regional network of associate hospitals and clinics used to support corporate, insurer, and patient healthcare programs. In 2016, Fullerton reported relationships with approximately 8,000 associate hospitals and clinics.
Controversies
2026
False entertainment-expense claims involving former executives
Former deputy group chief executive Daniel Chan Pai Sheng and former group chief executive Michael Tan Kim Song were fined over false or inflated entertainment-expense claims. The proceedings involved claims attributed to Chan and approvals attributed to Tan.
2025
Falsified claims case involving former co-founder David Sin
David Sin was fined S$160,000 for approving falsified claims exceeding S$213,000 on multiple occasions in 2019. The available material states that he knew another co-founder had submitted the claims with an intent to defraud Fullerton Healthcare Corp.
Brand decisions
2025
Strategic investment by Mitsubishi CorporationM&ABackground
Mitsubishi Corporation was pursuing regional healthcare expansion in Asia.
Action taken
Mitsubishi Corporation invested in Fullerton Health.
Aftermath
The investment linked Fullerton's regional healthcare platform with Mitsubishi Corporation's expansion strategy. The investment amount and ownership consequences are not specified in the available material.
2021
Pursuit of new financingStrategyBackground
The company sought new financing while facing internal disagreements.
Action taken
Fullerton pursued financing; founders subsequently initiated winding-up proceedings, which were later withdrawn.
Aftermath
The financing process was nearly derailed, but the available source does not provide the final financing terms or a complete account of the withdrawn proceedings.
2015
Acquisition-led expansion across three marketsM&ABackground
Fullerton sought to expand its regional healthcare platform and broaden its service capabilities through acquisitions in managed care, medical administration, Hong Kong healthcare delivery, and diagnostic imaging.
Action taken
Global Assistance & Healthcare acquired Indonesia's PT JLT GESA, Fullerton acquired an 80 percent stake in HMMP Limited in Hong Kong, and the group acquired Radlink-Asia in Singapore.
Aftermath
The transactions expanded Fullerton's geographic footprint and added diagnostic imaging and third-party administration capabilities.
Reported transaction values. HMMP Limited acquired for S$33 million; Radlink-Asia acquired for S$111.2 million (2015)
Sources1 sources
Cite this profile: Cite the canonical profile. /brand-wiki/fullerton-health-group · Editorial policy · How profiles are compiled